Osterweis Capital Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-7,980
Closed -$991K 109
2018
Q4
$991K Buy
+7,980
New +$1.31M 0.08% 85
2018
Q3
Sell
-14,283
Closed -$2.66M 116
2018
Q2
$2.66M Sell
14,283
-28,990
-67% -$4.82M 0.17% 81
2018
Q1
$5.32M Buy
43,273
+16,185
+60% +$1.98M 0.38% 52
2017
Q4
$3.23M Buy
27,088
+12,510
+86% +$1.38M 0.23% 67
2017
Q3
$1.39M Sell
14,578
-9,245
-39% -$891K 0.1% 84
2017
Q2
$2.27M Sell
23,823
-27,650
-54% -$2.36M 0.17% 68
2017
Q1
$3.99M Buy
51,473
+3,120
+6% +$216K 0.31% 49
2016
Q4
$3.25M Buy
48,353
+16,553
+52% +$1.02M 0.23% 49
2016
Q3
$1.91M Buy
+31,800
New +$1.77M 0.11% 58

Other funds holding INGN

Osterweis Capital Management's INGN Position: Q1 2019 in Review

Osterweis Capital Management sold out of Inogen (INGN) in Q1 2019, closing a stake of 7,980 shares — an estimated $991K sold.

Osterweis Capital Management first reported a position in INGN in Q3 2016 and held it in 9 quarters. The position peaked at $5.32M in Q1 2018. 239 funds tracked by Wall St. Rank hold INGN as of Q1 2019.

  • Osterweis Capital Management reported no remaining Inogen position as of Q1 2019 after selling out during the quarter.
  • Osterweis Capital Management sold 7,980 Inogen shares in Q1 2019, an estimated $991K.
  • Osterweis Capital Management first reported a position in Inogen in Q3 2016 and held it in 9 quarters.
  • Osterweis Capital Management's Inogen position peaked at $5.32M in Q1 2018.
  • 239 funds tracked by Wall St. Rank held Inogen as of Q1 2019.

Based on Osterweis Capital Management's 13F filing for Q1 2019, filed 15 May 2019.